Reference |
---|
Li K, Zhang Y, Liu X, Liu Y, Gu Z, Cao H, et al. Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies. Cancer Discov. 2020;10:724-745 pubmed publisher
|
Capozzi M, Savage S, McCollum G, Hammer S, Ramos C, Yang R, et al. The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis. Exp Eye Res. 2020;190:107885 pubmed publisher
|
Wagner K, Du S, Martin L, Leccia N, Michiels J, Wagner N. Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression. Cells. 2019;8: pubmed publisher
|
Cho R, Yang C, Tseng H, Hsiao L, Lin C, Yang C. Haem oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPARγ attenuates LPS-mediated lung inflammation. Br J Pharmacol. 2018;175:3928-3946 pubmed publisher
|
Yang D, Vuckovic M, Smullin C, Kim M, Lo C, Devericks E, et al. Modest Decreases in Endogenous All-trans-Retinoic Acid Produced by a Mouse Rdh10 Heterozygote Provoke Major Abnormalities in Adipogenesis and Lipid Metabolism. Diabetes. 2018;67:662-673 pubmed publisher
|
Xiao L, Dong J, Teng X, Jin S, Xue H, Liu S, et al. Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta/endothelial nitric oxide synthase signaling. J Hypertens. 2018;36:651-665 pubmed publisher
|
Valanejad L, Ghareeb M, Shiffka S, Nadolny C, Chen Y, Guo L, et al. Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms. Mol Cell Endocrinol. 2018;470:127-141 pubmed publisher
|
Sun L, Shi Y, Wang G, Wang X, Zeng S, Dunn S, et al. PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells. Leukemia. 2018;32:184-193 pubmed publisher
|
Duncan G, Firth K, George V, Hoang M, Staniforth A, Smith G, et al. Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Stem Cells Dev. 2017;26:1695-1705 pubmed publisher
|
Heck B, Park J, Makani V, Kim E, Kim D. PPAR-δ Agonist With Mesenchymal Stem Cells Induces Type II Collagen-Producing Chondrocytes in Human Arthritic Synovial Fluid. Cell Transplant. 2017;26:1405-1417 pubmed publisher
|
Opitz L, Kling K, Brandenberger C, Mühlfeld C. Lipid-body containing interstitial cells (lipofibroblasts) in the lungs of various mouse strains. J Anat. 2017;231:970-977 pubmed publisher
|
Kwok W, Choi T, Tsoi Y, Leung G, Wan T. Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control. J Chromatogr A. 2017;1490:89-101 pubmed publisher
|
Singh A, Liu J. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor ?. J Biol Chem. 2017;292:884-897 pubmed publisher
|
Morales Cano D, Moreno L, Barreira B, Briones A, Pandolfi R, Moral Sanz J, et al. Activation of PPAR?/? prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries. Clin Sci (Lond). 2016;130:1823-36 pubmed publisher
|
Kawaguchi K, Senga S, Kubota C, Kawamura Y, Ke Y, Fujii H. High expression of Fatty Acid-Binding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells. FEBS Open Bio. 2016;6:190-9 pubmed publisher
|